CompletedInterventionalNot ApplicableUpdated Jan 9, 2015
Opioid Maintenance Medications Comparison Study | NCT00344812 | Trialant
CompletedInterventionalPhase 2Updated Jun 27, 2006
Opioid Maintenance Medications Comparison Study
ClinicalTrials.gov ID
NCT00344812
Lead Sponsor
Johns Hopkins UniversityOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Phase 2
Enrollment
220
Last Update Posted
Jun 27, 2006Estimated
Start Date
Jan 1996
Completion Date
Jun 1998
Brief Summary
A 17 week, double-blind, randomized, parallel group, four arm design outpatient study comparing LAAM, buprenorphine and two dose levels of methadone for the treatment of opioid dependence.
Opioid Dependence
LAAM. buprenorphine and methadone
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion
age 21 to 55 years
diagnosis of opioid dependence by criteria of the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV)
evidence of recent opioid use on toxicologic screening
Exclusion
serious medical or psychiatric illness requiring long-term medication
positive pregnancy test
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Double
No central contacts
There are no central contacts for this study.
Behavioral Pharmacology Research Unit; Johns Hopkins Bayview Campus